# KOSELUGO

NDC: 0310-0610
Generic name: SELUMETINIB
Labeler / Manufacturer: AstraZeneca Pharmaceuticals LP
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20200416

FDA application: NDA213756

## Active ingredients

- SELUMETINIB: 10 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0310-0610"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0310-0610
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7d042c61-f28f-4ab5-ab10-d7558c0d49ff